LifeMatrix Technologies AG

LifeMatrix is active in the field of medical biomimetics and has developed a unique bio-engineering technology to grow human replacement tissues in the laboratory as next generation implants for the treatment of cardiovascular diseases. The patented LifeMatrix tissues can be produced as heart valves, blood vessels and other structures. When implanted, the patient's own cells transform the LifeMatrix implants into living tissue which can grow and regenerate with the patient. LifeMatrix implants are off-the-shelf products, scalable, cost-effective, non-immunogenic and applicable to every patient. The disruptive LifeMatrix technology has the potential to overcome the significant limitations of existing implants and revolutionize the medical device industry.